Building a growing genomic data repository for maternal and fetal health through the PING Consortium
Authors: Abdelmalek Clara M. , Singh Shriya , Fasil Blain , Horvath Allison R. , Mulkey Sarah B. , Curé Carlos , Campos Maribel , Cavalcanti Denise P. , Tong Van T. , Mercado Marcela , Daza Marcela , Marcela Benavides Mónica , Acosta Jacqueline , Gilboa Suzanne , Valencia Diana , Sancken Christina L. , Newton Suzanne , Scalabrin Deolinda M. F. , Mussi-Pinhata Marisa M. , Vasconcelos Zilton , Chakhtoura Nahida , Moye Jack , Leslie Elizabeth J. , Bulas Dorothy , Vezina Gilbert , Marques Fernanda J. P. , Leyser Marcio , Del Campo Miguel , Vilain Eric , DeBiasi Roberta L. , Wang Tongguang , Nath Avindra , Haydar Tarik , Muenke Max , Mansour Tamer A. , du Plessis Adre J. , Murray Jeffrey C. , Cordero José F. , Kousa Youssef A. 
Published: May 2024

Background

Prenatally transmitted viruses can cause severe damage to the developing brain. There is unexplained variability in prenatal brain injury and postnatal neurodevelopmental outcomes, suggesting disease modifiers. Discordant outcomes among dizygotic twins could be explained by genetic susceptibly or protection. Among several well-recognized threats to the developing brain, Zika is a mosquito-borne, positive-stranded RNA virus that was originally isolated in Uganda and spread to cause epidemics in Africa, Asia, and the Americas. In the Americas, the virus caused congenital Zika syndrome and a multitude of neurodevelopmental disorders. As of now, there is no preventative treatment or cure for the adverse outcomes caused by prenatal Zika infection. The Prenatal Infection and Neurodevelopmental Genetics (PING) Consortium was initiated in 2016 to identify factors modulating prenatal brain injury and postnatal neurodevelopmental outcomes for Zika and other prenatal viral infections.

Methods

The Consortium has pooled information from eight multi-site studies conducted at 23 research centers in six countries to build a growing clinical and genomic data repository. This repository is being mined to search for modifiers of virally induced brain injury and developmental outcomes. Multilateral partnerships include commitments with Children’s National Hospital (USA),Instituto Nacional de Salud(Colombia), the Natural History of Zika Virus Infection in Gestation program (Brazil), and ZikaInstituto Fernandes Figueira(Brazil), in addition to the Centers for Disease Control and Prevention and the National Institutes of Health.

Discussion

Our goal in bringing together these sets of patient data was to test the hypothesis that personal and populational genetic differences affect the severity of brain injury after a prenatal viral infection and modify neurodevelopmental outcomes. We have enrolled 4,102 mothers and 3,877 infants with 3,063 biological samples and clinical data covering over 80 phenotypic fields and 5,000 variables. There were several notable challenges in bringing together cohorts enrolled in different studies, including variability in the timepoints evaluated and the collected clinical data and biospecimens. Thus far, we have performed whole exome sequencing on 1,226 participants. Here, we present the Consortium’s formation and the overarching study design. We began our investigation with prenatal Zika infection with the goal of applying this knowledge to other prenatal infections and exposures that can affect brain development.